Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|March 17, 2006
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonistSerena Scapecchi, Rosanna Matucci, Cristina Bellucci, et al.Journal of Medicinal Chemistry|November 26, 2009
Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structureSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.Biomolecules|July 29, 2025
Dissecting the tRNA Fragment tRF3E-Nucleolin Interaction: Implications in Breast CancerMaurizio Falconi, Junbiao Wang, Andrea Costamagna, et al.Journal of Medicinal Chemistry|August 28, 2019
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic PainMatteo Falsini, Daniela Catarzi, Flavia Varano, et al.Molecules (Basel, Switzerland)|April 23, 2022
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?Andrea Spinaci, Catia Lambertucci, Michela Buccioni, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2026
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agentsMarianna Grignolo, Andrea Spinaci, Ludovica Ricci, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
"Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling StudiesAndrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 12, 2025
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatmentAkshaya Murugesan, Aleksei Smirnov, Anxo Vila Alonso, et al.Pharmacological Research|August 22, 2020
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic miceJunbiao Wang, Romilde Iannarelli, Stefania Pucciarelli, et al.Journal of Medicinal Chemistry|April 17, 2010
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptorEnrica Calleri, Stefania Ceruti, Gloria Cristalli, et al.Pageof 11